TrialPloS one2013

The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.

Fei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.